As India confronts a sharp rise in cancer incidence, Gleneagles Hospital, Parel, Mumbai, has launched the Institute of Onco-Science, a fully integrated and coordinated cancer care centre. The new institute aims to deliver faster diagnosis, multidisciplinary expertise, and advanced treatment within a single, seamless care ecosystem.
Cancer Burden in India Continues to Rise
Cancer has emerged as one of India’s most pressing public health challenges. According to a recent study by the Indian Council of Medical Research (ICMR) published in the Journal of the American Medical Association (JAMA), India is projected to record 1.56 million new cancer cases and 874,404 deaths in 2024.
Notably, breast cancer, gastrointestinal and hepatopancreatobiliary (GI & HPB) cancers, head and neck cancers, and uro-oncological cancers are rising rapidly. Factors such as chronic stress, lifestyle changes, environmental exposure, and low screening uptake continue to drive this alarming trend.
Bringing India’s Leading Cancer Experts Under One Roof
To address the urgent need for timely and structured cancer care, Gleneagles Hospital has brought together some of the country’s most respected oncology specialists at the Institute of Onco-Science:
- Shailesh V. Shrikhande – GI and HPB Cancer
- Dr Prathamesh Pai – Head & Neck Cancer
- Dr Pradeep Rao – Uro-Oncology
- Dr Tushar Jadhav – Breast Cancer
Together, this expert team brings decades of high-volume clinical experience, research leadership, and excellence in organ-specific oncology.
Eliminating Fragmentation in Cancer Care
Traditionally, cancer patients often navigate multiple hospitals and departments, leading to delays and confusion. In contrast, the Institute of Onco-Science removes this fragmentation by offering a single-window model of care.
Patients benefit from coordinated access to all major cancer specialties, faster and integrated diagnostic evaluations, and unified treatment planning. This approach ensures clarity for patients and families while improving clinical efficiency.
In addition, the institute provides access to precision oncology, advanced treatment technologies, and comprehensive support services such as counselling, nutrition guidance, and survivorship care. As a result, patients experience reduced emotional and financial burden throughout their treatment journey.
Focus on Early Detection and Personalised Treatment
As per the press release, the institute places strong emphasis on preventive and personalised cancer care. Key priorities include early detection and targeted screening for high-risk populations, minimally invasive and advanced treatment options for faster recovery, evidence-based personalised care pathways, and structured long-term follow-up and survivorship programmes.
By integrating innovation with empathy and specialist-led care, the centre aims to raise the standard of cancer treatment in Mumbai and extend its impact across the region.
Leadership Perspective on the Institute’s Vision
Commenting on the launch, Dr Bipin Chevale, CEO of Gleneagles Hospital Mumbai, said the Institute of Onco-Science arrives at a critical time when cancer continues to affect countless families across the country.
He emphasised that cancer disrupts not only physical health but also hope, stability, and family futures. By uniting leading specialists under one roof, he noted, Gleneagles aims to deliver timely, coordinated, and compassionate care to every patient.
He further added that strengthening early detection and ensuring equitable access to expert cancer care remains central to Gleneagles’ mission. According to him, the institute marks a significant step toward building a future where cancer care is organised, accessible, and delivered with empathy.